From IPO to Shareholder Success: DSS Inc. Cheers on Impact BioMedical Inc.’s Big Win!
Exciting News in the Biomedical Industry! NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the successful pricing of Impact BioMedical’s initial public offering (IPO). Impact BioMedical, a trailblazer in advancing human healthcare and wellness…